| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |